Shandong Oriental Ocean Sci-Tech Co., Ltd. wholly-owned subsidiary Avioq Bio-Tech Co., Ltd. has independently developed a neutrophil gelatinase-associated lipocalin test kit using fluorescence immunochromatography, and has obtained a medical device registration certificate from the Shandong Medical Products Administration. The registration certificate number is Lu Xie Zhu Zhun 20262400300, valid from July 23, 2026 to July 22, 2031. The product is used for in vitro quantitative determination of neutrophil gelatinase-associated lipocalin levels in human whole blood and serum. Previously, on July 28, 2026, the company announced the approval of a magnetic particle chemiluminescence kit from the same series. This latest certification further enriches the subsidiary's clinical testing product line. The company stated that the subsidiary's impact on this year's performance is minimal, the product has not yet been put into production, and actual sales are subject to multiple factors such as market expansion and demand. It is currently unable to predict the specific impact on future performance.
Shandong Oriental Ocean Sci-Tech Co LtdSubsidiary's new test kit received medical device registration certificate, expanding product line.
Avioq Bio-Tech obtained registration for its independently developed test kit, enhancing its clinical testing portfolio.